Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Publisher
Journal of Clinical Endocrinology and Metabolism(2)
Frontiers in Endocrinology(1)
Journal of the Endocrine Society(1)
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(2)
Fisiología humana(2)
Ginecología, obstetricia, pediatría, geriatría(2)
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(4)
ODS 3: Salud y bienestar(4)
ODS 5: Igualdad de género(4)
Origen
scopus(4)
11-Oxygenated Androgens Useful in the Setting of Discrepant Conventional Biomarkers in 21-Hydroxylase Deficiency
ArticleAbstract: Context: Serum 17-hydroxyprogesterone (17OHP) and androstenedione (A4) are the conventional biomarkePalabras claves:alternate androgens, androgen excess, Biomarkers, Congenital adrenal hyperplasia, monitoring therapy, steroidogenesisAutores:Brookner B., Jha S., Merke D.P., Richard J. Auchus, Sinaii N., Turcu A.F.Fuentes:scopus24-Hour Profiles of 11-Oxygenated C<inf>19</inf> Steroids and Δ<sup>5</sup>-Steroid Sulfates during Oral and Continuous Subcutaneous Glucocorticoids in 21-Hydroxylase Deficiency
ArticleAbstract: Background: Optimal management of androgen excess in 21-hydroxylase deficiency (21OHD) remains challPalabras claves:11-oxyandrogens, 21-hydroxylase deficiency, CAH, Circadian hormones, Congenital adrenal hyperplasia, cortisol 24-hour profileAutores:Byrd J.B., Chen X., Mallappa A., Merke D.P., Nanba A.T., Nella A.A., Richard J. Auchus, Turcu A.F., Zhao L.Fuentes:scopusA Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia
ArticleAbstract: Context: Patients with classic congenital adrenal hyperplasia (CAH) often require supraphysiologic gPalabras claves:adrenal hypertrophy, ATR-101, Clinical trial, Congenital adrenal hyperplasia, nevanimibeAutores:Chang A.Y., El-Maouche D., Joyal E.G., Lin V.H., Merke D.P., Mohideen P., Plaunt M.R., Richard J. Auchus, Turcu A.F., Vogiatzi M.G., Weintraub L.Fuentes:scopusTildacerfont in Adults with Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies
ArticleAbstract: Context: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD) is typically treatePalabras claves:17-hydroxyprogesterone, adrenocorticotropic hormone, androstenedione, Congenital adrenal hyperplasia, CRF-receptor antagonist, tildacerfontAutores:Barnes C.N., Huang M., Imel E.A., Madu I.J., Merke D.P., Moriarty D., Nakhle S., Newfield R.S., Richard J. Auchus, Sarafoglou K., Vogiatzi M.G.Fuentes:scopus